Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

227 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Is levodopa toxic?
Müller T, Hefter H, Hueber R, Jost WH, Leenders KL, Odin P, Schwarz J. Müller T, et al. Among authors: odin p. J Neurol. 2004 Sep;251 Suppl 6:VI/44-6. doi: 10.1007/s00415-004-1610-x. J Neurol. 2004. PMID: 15675725 Review.
Peripheral neuropathy in Parkinson's disease: levodopa exposure and implications for duodenal delivery.
Müller T, van Laar T, Cornblath DR, Odin P, Klostermann F, Grandas FJ, Ebersbach G, Urban PP, Valldeoriola F, Antonini A. Müller T, et al. Among authors: odin p. Parkinsonism Relat Disord. 2013 May;19(5):501-7 ; discussion 501. doi: 10.1016/j.parkreldis.2013.02.006. Epub 2013 Feb 27. Parkinsonism Relat Disord. 2013. PMID: 23453891 Free article. Review.
Expert Consensus Group report on the use of apomorphine in the treatment of Parkinson's disease--Clinical practice recommendations.
Trenkwalder C, Chaudhuri KR, García Ruiz PJ, LeWitt P, Katzenschlager R, Sixel-Döring F, Henriksen T, Sesar Á, Poewe W; Expert Consensus Group for Use of Apomorphine in Parkinson's Disease; Baker M, Ceballos-Baumann A, Deuschl G, Drapier S, Ebersbach G, Evans A, Fernandez H, Isaacson S, van Laar T, Lees A, Lewis S, Martínez Castrillo JC, Martinez-Martin P, Odin P, O'Sullivan J, Tagaris G, Wenzel K. Trenkwalder C, et al. Among authors: odin p. Parkinsonism Relat Disord. 2015 Sep;21(9):1023-30. doi: 10.1016/j.parkreldis.2015.06.012. Epub 2015 Jun 17. Parkinsonism Relat Disord. 2015. PMID: 26189414 Review.
Tolerability of non-ergot oral and transdermal dopamine agonists in younger and older Parkinson's disease patients: an European multicentre survey.
Rizos A, Sauerbier A, Falup-Pecurariu C, Odin P, Antonini A, Martinez-Martin P, Kessel B, Henriksen T, Silverdale M, Durner G, Ray Chaudhuri K; EUROPAR and the IPMDS Non-Motor PD Study Group. Rizos A, et al. Among authors: odin p. J Neural Transm (Vienna). 2020 Jun;127(6):875-879. doi: 10.1007/s00702-020-02168-0. Epub 2020 May 5. J Neural Transm (Vienna). 2020. PMID: 32372166 Free PMC article.
Parkinson's Disease and Post-COVID-19 Syndrome: The Parkinson's Long-COVID Spectrum.
Leta V, Rodríguez-Violante M, Abundes A, Rukavina K, Teo JT, Falup-Pecurariu C, Irincu L, Rota S, Bhidayasiri R, Storch A, Odin P, Antonini A, Ray Chaudhuri K. Leta V, et al. Among authors: odin p. Mov Disord. 2021 Jun;36(6):1287-1289. doi: 10.1002/mds.28622. Epub 2021 Apr 28. Mov Disord. 2021. PMID: 33890344 Free PMC article. No abstract available.
Non-motor predictors of 36-month quality of life after subthalamic stimulation in Parkinson disease.
Jost ST, Visser-Vandewalle V, Rizos A, Loehrer PA, Silverdale M, Evans J, Samuel M, Petry-Schmelzer JN, Sauerbier A, Gronostay A, Barbe MT, Fink GR, Ashkan K, Antonini A, Martinez-Martin P, Chaudhuri KR, Timmermann L, Dafsari HS; EUROPAR and the International Parkinson and Movement Disorders Society Non-Motor Parkinson’s Disease Study Group. Jost ST, et al. NPJ Parkinsons Dis. 2021 Jun 8;7(1):48. doi: 10.1038/s41531-021-00174-x. NPJ Parkinsons Dis. 2021. PMID: 34103534 Free PMC article.
Digital health technology for non-motor symptoms in people with Parkinson's disease: Futile or future?
van Wamelen DJ, Sringean J, Trivedi D, Carroll CB, Schrag AE, Odin P, Antonini A, Bloem BR, Bhidayasiri R, Chaudhuri KR; International Parkinson and Movement Disorder Society Non Motor Parkinson's Disease Study Group. van Wamelen DJ, et al. Among authors: odin p. Parkinsonism Relat Disord. 2021 Aug;89:186-194. doi: 10.1016/j.parkreldis.2021.07.032. Epub 2021 Jul 31. Parkinsonism Relat Disord. 2021. PMID: 34362670 Review.
Levodopa Dose Equivalency in Parkinson's Disease: Updated Systematic Review and Proposals.
Jost ST, Kaldenbach MA, Antonini A, Martinez-Martin P, Timmermann L, Odin P, Katzenschlager R, Borgohain R, Fasano A, Stocchi F, Hattori N, Kukkle PL, Rodríguez-Violante M, Falup-Pecurariu C, Schade S, Petry-Schmelzer JN, Metta V, Weintraub D, Deuschl G, Espay AJ, Tan EK, Bhidayasiri R, Fung VSC, Cardoso F, Trenkwalder C, Jenner P, Ray Chaudhuri K, Dafsari HS; International Parkinson and Movement Disorders Society Non-Motor Parkinson Disease Study Group. Jost ST, et al. Among authors: odin p. Mov Disord. 2023 Jul;38(7):1236-1252. doi: 10.1002/mds.29410. Epub 2023 May 5. Mov Disord. 2023. PMID: 37147135
227 results